Nonopioid Chronic Pain Solution

The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to interim results of the BENEFIT-03 study.

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment.